" class="no-js "lang="en-US"> Valentin Barsan - Medtech Alert
Tuesday, January 14, 2025
Vali Barsan

Valentin Barsan

About Valentin Barsan

Implementing clinical diagnostics and molecular tools to personalize cancer therapy.

I have developed extensive experience in molecular biology techniques of PCR and NGS, including DNA-seq and RNA-seq protocols, TCR sequencing, gene editing (CRISPR/Cas systems), and various target-enrichment approaches (multiplex-PCR, hybrid selection, host depletion, single cell isolation) as well as CAR T cell design, production, and clinical use. I am interested in developing tools and datasets of epitope prediction/validation, HLA gene analysis, MHC characterizing, mathematical modeling of immune-cancer interactions, and network analysis of immune system data to develop novel cancer therapies for patients.

Related Story

Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease

March 30 2022

Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined […]